Delivery Order SPE2DB22D1106-SPE2DB24FEXX9
Award Date
6/20/24
Potential Completion Date
7/12/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,467.60, is a delivery order for the supply of 4557786416 HYPERRHO S-D 250 UNIT SYRINGES. The contract has a firm fixed price pricing type and an ultimate completion date of August 3, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 1,500 units of HYPERRHO S-D syringes. The $2,388.50 award does not have a set-aside designation and is to be completed by February 9, 2024. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this order, which is part of the company's broader indefinite delivery contract with the DLA to provide...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The firm-fixed-price, $9,391.75 contract has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order to provide HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $13,494.72 with a completion date of July 15, 2024, is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of a specific pharmaceutical product, HYPERRAB 300 UNIT/ML VIAL 5ML. The contract has a ceiling value of $3,677.16 and a completion date of January 12, 2024. This is a firm fixed price delivery order contract....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,325.50, is for the delivery of medical supplies, specifically "HYPERRAB 300UNIT/ML 1S". The contract is a Firm Fixed Price Delivery Order with a completion date of May 5, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML pharmaceutical product to the Defense Logistics Agency (DLA). The $1,124.56 firm-fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The $13,398.48 Firm Fixed Price Delivery Order contract is for the provision of HYPERRAB 300UNIT/ML 1S, a medication. The contract has a completion date of June 10, 2024. Amerisourcebergen holds a much larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,886.54 firm fixed-price delivery order is for the supply of HYPERRAB 300UNIT/ML 1S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the supply of a pharmaceutical product, HYPERRAB 300 UNIT/ML VIAL, to the Defense Logistics Agency (DLA). The $4,466.28 firm fixed-price delivery order has a performance period through June 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...